Intermune Ex-Chief Harkonen Sentenced to Home Confinement
This article is for subscribers only.
W. Scott Harkonen, Intermune Inc.’s former chief executive officer, was sentenced to six months of home confinement and fined $20,000 for his role in disseminating misleading information about the drug Actimmune for the treatment of lung disease, the Justice Department said today.
Harkonen was convicted by a federal jury of wire fraud in September 2009 after a three-week trial. A physician, the ex-Intermune CEO was accused of crafting a deceptive press release in 2002 to boost sales of Actimmune, prosecutors said. U.S. District Judge Marilyn Patel also sentenced Harkonen to three years’ probation at a hearing yesterday.